Cracking the Sulfur Code: Garlic Bioactive Molecules as Multi-Target Blueprints for Drug Discovery

Area of Science:

• Herbal medicine and pharmacology
• Natural product chemistry
• Computational chemistry and drug discovery

Background:

• Garlic (Allium sativum L.) has a long history of use as both food and medicine.
• Its bioactive compounds, such as allicin and organosulfur derivatives, exhibit diverse pharmacological effects.
• These effects include antioxidant, anti-inflammatory, antithrombotic, anticancer, antimicrobial, and neuroprotective properties.

Purpose of the Study:

• To explore the mechanistic basis of garlic's therapeutic properties.
• To investigate the role of computational methods in understanding garlic's bioactive compounds.
• To assess formulation strategies for enhancing garlic-derived pharmaceuticals.

Main Methods:

• Mechanistic studies on redox homeostasis, inflammation, platelet activation, and apoptosis.
• Computational approaches including Density Functional Theory (DFT), molecular docking, molecular dynamics, and MM-GBSA.
• In silico ADME/Tox predictions and Artificial Intelligence/Machine Learning (AI/ML) pipelines.
• Formulation strategies like nanoencapsulation and controlled-release systems.

Main Results:

• Garlic compounds modulate key biological pathways relevant to various diseases.
• Computational studies provide molecular-level insights into antioxidant and pharmacological activities.
• In silico models predict favorable pharmacokinetic profiles for some compounds, with limitations in brain penetration for polar derivatives.
• AI/ML aids in target identification and drug development prioritization.
• Formulation approaches can stabilize active compounds and control their release.

Conclusions:

• Integrating mechanistic, computational, and formulation data offers a systematic pathway for developing garlic-derived agents.
• Computational and formulation strategies are crucial for advancing natural products into reproducible pharmaceuticals.
• Addressing challenges in standardization and pharmacokinetic variability is key for clinical translation.